FDA U.S. Agent for Medical Devices in 2026: Requirements, Registration, Responsibilities and Fees

Quick Summary: What Is an FDA U.S. Agent?

An FDA U.S. Agent is a person or organization residing in, or maintaining a business presence in, the United States that a foreign medical device establishment designates as its FDA contact. For covered establishments, appointing an agent is part of FDA registration, not an optional service.

The agent helps FDA contact the establishment, answers questions about imported devices, and assists with arranging inspections. The agent does not automatically become the manufacturer, importer, 510(k) submitter, or person responsible for adverse event reporting. Each foreign establishment identifies one agent through FDA's electronic registration system, and that agent must confirm consent.

At a glance: One agent per foreign establishment; U.S. physical presence required; confirmation within 10 business days; no automatic responsibility for 510(k) submissions or adverse event reporting. Appointment does not replace device clearance, listing, quality system obligations, or cybersecurity evidence.

Who Needs an FDA U.S. Agent for Medical Devices?

Foreign establishments engaged in manufacturing, preparing, processing, or related activities involving medical devices imported or offered for import into the United States generally must identify a U.S. Agent. Applicability depends on the establishment's activities and FDA registration rules, not simply on where a company's headquarters are located. These requirements should also be considered alongside applicable FDA cybersecurity requirements for medical devices.

Manufacturers in India, Germany, Singapore, and other countries may need agents when foreign facilities register to supply U.S. devices. Contract manufacturers and other foreign establishments should check their specific activity categories rather than assuming that the finished device brand owner alone fulfills every obligation.

A U.S. business address does not convert a foreign facility into a domestic establishment. Distributors do not automatically eliminate agent obligations.

What Does an FDA U.S. Agent Do?

The agent's statutory role is primarily a communications and inspection coordination function. FDA identifies four central duties:

• Assist FDA in communicating with the foreign establishment.
• Respond to FDA questions concerning the establishment's imported or offered devices.
• Help FDA schedule inspections at the foreign establishment.
• Receive FDA information or documents when the agency cannot contact the establishment directly or promptly.

In the last circumstance, delivery to the agent can count as delivery to the establishment. This makes contact accuracy and prompt escalation operationally important, even though the role is limited.

Agents should know manufacturer contacts in regulatory, quality, and management teams. Agree on escalation, response expectations, confidentiality, and continuity.

What Is the Agent Not Required to Do?

An FDA U.S. Agent is not automatically responsible for submitting a 510(k) or reporting adverse events under 21 CFR Part 803. FDA expressly separates those responsibilities from the registration agent role. Manufacturers remain accountable for applicable device requirements, and separate arrangements may be needed for regulatory consulting or submission preparation.

What Qualifications Must an FDA U.S. Agent Meet?

The agent must reside in the United States or maintain a U.S. place of business. FDA does not accept a post office box or a standalone answering service as the agent's physical presence.

The agent must be reachable by telephone, personally or through an employee, during normal business hours. The foreign establishment supplies identifying and contact details, including address, phone number, and email, during registration.

The agent may be an eligible person or organization. FDA does not require every manufacturer to purchase representation from a particular consultancy, nor does it endorse commercial agents. Assess availability, regulatory experience, consent, and correspondence procedures.

How Do Foreign Manufacturers Appoint an FDA U.S. Agent?

Foreign establishments appoint an FDA U.S. Agent through the FDA Unified Registration and Listing System (FURLS), within the Device Registration and Listing Module (DRLM); the designated agent must verify consent. The sequence is:

1. Determine which foreign establishments must register and designate an agent.
2. Select an eligible U.S. contact and agree on duties, availability, and escalation arrangements.
3. Prepare the establishment's business details, activity classifications, and agent contact information.
4. Complete applicable establishment registration and device listing steps through FDA's electronic systems.
5. Enter the selected agent's information and monitor the automatic verification request.
6. Confirm the agent accepts the designation and retain registration communications.
7. Update the FDA record when contacts or establishment details change.

FDA sends an electronic consent request to the proposed agent. If consent is denied or no response arrives within ten business days, the establishment is notified and must designate another agent.

Is an FDA U.S. Agent the Same as an Official Correspondent?

No. The U.S. Agent and official correspondent are separate registration roles, although the same eligible person may perform both. The agent facilitates FDA communication with the foreign establishment. The official correspondent handles designated registration communications and information management within the FDA system.

Foreign establishments may designate their agent as official correspondent, but are not required to do so. Assigning responsibilities clearly helps avoid overlooked renewal notices, conflicting contact information, and uncertainty about who can update records.

Is an FDA U.S. Agent the Same as a U.S. Importer?

No. An initial importer and an FDA U.S. Agent have different regulatory functions. Importers participate in bringing devices into U.S. commercial distribution and may have their own establishment registration and other applicable obligations. An agent primarily serves as the communication link between FDA and a foreign establishment.

One company can sometimes fill multiple roles, but that does not merge their legal responsibilities. Review importer arrangements separately, especially when commercial partners change.

How Much Does an FDA U.S. Agent Cost in 2026?

FDA does not publish a mandatory commercial fee that every U.S. Agent must charge. Agent service charges are determined by the provider and any agreed scope. They should not be confused with FDA establishment registration user fees.

For FDA fiscal year 2027 (October 1, 2026–September 30, 2027), the annual medical device establishment registration fee is $13,785. This is a government fee for covered establishments, not a payment to the agent. Some eligible small businesses may qualify for a hardship waiver of the annual fee, excluding initial registration, under specified FDA criteria.

A cost proposal should distinguish government fees, agent representation, device listing assistance, regulatory consulting, and any 510(k) preparation or cybersecurity assessment. Avoid quotations implying that a paid agent appointment itself grants FDA market authorization.

When Must Registration and Agent Details Be Updated?

FDA requires annual establishment registration review between October 1 and December 31, even if information has not changed. Device listings must also be reviewed during the annual cycle. Initial registration timing and prerequisites depend on the establishment and product circumstances; foreign establishments must register before exporting applicable devices to the United States.

Review agent contact information whenever personnel, provider relationships, addresses, or telephone numbers change. Changes should be entered promptly through the establishment registration system; verify applicable FDA update timelines. Maintaining current records matters because FDA may use those details when contacting manufacturers about inspections or imported products.

Registration is not FDA approval. A facility appearing in the registration database does not establish that its devices are cleared, approved, or authorized for sale.

How Does an FDA U.S. Agent Relate to 510(k) and Cybersecurity?

A U.S. Agent designation does not satisfy 510(k), Quality Management System Regulation, or medical device cybersecurity requirements. These are distinct regulatory workstreams that often overlap during market entry planning.

For example, a connected patient monitoring device may require a premarket submission addressing software architecture, threat modeling, cybersecurity risk management, verification evidence, and an SBOM when statutory cyber device requirements apply. The manufacturer's U.S. Agent can help FDA reach the establishment, but is not automatically responsible for developing that technical evidence.

Manufacturers can coordinate agent selection alongside FDA premarket cybersecurity documentation and Medical Device Penetration Testing so regulatory communication and security validation have clear ownership.

What Are Common FDA U.S. Agent Registration Mistakes?

The most avoidable failures involve misunderstanding the agent's scope or maintaining inaccurate registration data. Common examples include selecting an unreachable contact, using a mailbox address, overlooking the verification email, assuming an importer is automatically the agent, or treating registration as product clearance.

Manufacturers may also confuse a regulatory representative with a submission author. A 510(k) consultant can support preparation and strategy, but the registration agent role alone does not include submission delivery. Similarly, device cybersecurity assessments require technical specialists and a defined testing scope; simply appointing an agent creates no security assurance.

An internal responsibility matrix should identify owners for establishment registration, device listing, submission readiness, cybersecurity evidence, adverse event reporting, recalls, and FDA correspondence. Review that matrix before commercialization and whenever business relationships change.

How Should Manufacturers Choose an FDA U.S. Agent?

Choose an agent based on demonstrable availability, reliable FDA communication, and transparent service boundaries. Ask whether the provider maintains an eligible physical U.S. presence, answers during business hours, confirms appointments promptly, and has an escalation procedure for urgent regulatory correspondence.

Clarify renewals, confidentiality, termination, replacement, records transfer, and whether additional services are explicitly included.

An effective arrangement remains functional during inspections, personnel transitions, and unexpected requests.

How Does Medysec Support FDA Cybersecurity Readiness?

Medysec, the MedTech cybersecurity division of Qualysec Technologies, supports medical device manufacturers with security testing, FDA cybersecurity documentation, deficiency response, and lifecycle risk management. These services complement, rather than replace, the legally defined FDA U.S. Agent function.

Medysec Medical Device Cybersecurity Services

Conclusion

An FDA U.S. Agent provides a required communication link for covered foreign medical device establishments entering the American market. Successful compliance requires an eligible, responsive contact and accurate registration records, alongside the manufacturer's independent obligations for device listing, market authorization, quality systems, and cybersecurity. Treating those responsibilities separately creates a clearer regulatory pathway to U.S. market entry.

Explore Medysec cybersecurity and compliance solutions to coordinate device security evidence with broader U.S. regulatory preparation. Confirm any separate U.S. Agent representation directly before assuming it is included.

Is Your Medical Device Secure?

Check your medical device security risks and find the right steps to protect patient data and meet cybersecurity requirements.

Speak with Our Experts →

Frequently Asked Questions About FDA U.S. Agents

1. Can a foreign manufacturer appoint more than one U.S. Agent?

No. FDA allows one designated U.S. Agent per foreign establishment. Different foreign establishments may designate their own agents.

2. Can the U.S. Agent submit a 510(k)?

The appointment alone does not create a 510(k) submission obligation. Separate authorization and services may be arranged when appropriate.

3. Does an FDA U.S. Agent guarantee approval?

No. Agent designation and establishment registration do not constitute product clearance, approval, or authorization.

4. What happens if the proposed agent never confirms?

If the agent does not consent within ten business days, the establishment must identify another eligible agent.